Treating relapsed or refractory Philadelphia chromosome-negative acute lymphoblastic leukemia: liposome-encapsulated vincristine
Tyler Davis, Sherif S Farag Department of Internal Medicine, Division of Hematology and Oncology, Indiana University School of Medicine, Indianapolis, IN, USA Abstract: Acute lymphoblastic leukemia (ALL) remains a disease with poor outcomes in adults. While induction chemotherapy achieves a complete...
Enregistré dans:
Auteurs principaux: | Davis T, Farag SS |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/4b3cc98f6a52462583d9f6b9dcc9c5a6 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Vincristine sulfate liposomal injection for acute lymphoblastic leukemia
par: Soosay Raj TA, et autres
Publié: (2013) -
Vincristine sulfate liposomal injection for acute lymphoblastic leukemia [Corrigendum]
par: Soosay Raj TA, et autres
Publié: (2013) -
Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia with kinase fusions in Taiwan
par: Yin-Chen Hsu, et autres
Publié: (2021) -
Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives
par: Anagnostou T, et autres
Publié: (2017) -
Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives [Erratum]
par: Anagnostou T, et autres
Publié: (2018)